Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Manage your formulary budget
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Method of bowel cleansing|
|Abstract:||Stimulant laxative in combination with an osmotic laxative produces safe and effective bowel and colon cleansing with a reduced volume of liquid input. Administering to a patient an oral stimulant laxative, such as bisacodyl, followed, after a biologically determined interval, by a reduced volume of a PEG in water solution cleanses the bowels and colon in preparation for diagnostic colonoscopy, without the profuse uncontrollable diarrhea that typically follows either ingestion of large volume isotonic ravages, or smaller volume hypertonic lavages.|
|Inventor(s):||Dennett, Jr.; Edmund V. (Walpole, MA), Raleigh, Jr.; Robert M. (Braintree, MA), Cleveland; Mark V B. (Duxbury, MA), Pelham; Russell W. (Duxbury, MA)|
|Assignee:||Braintree Laboratories Inc. (Braintree, MA)|
1. A method for cleansing bowels and colon of a mammal, the method consisting essentially of: a) orally administering to the mammal from about 5 mg to about 40 mg of
bisacodyl; b) waiting until the bisacodyl produces a bowel movement, the bowel movement occurring within 6 hours; c) orally administering to the mammal from about 50 g to about 400 g of polyethylene glycol (PEG) in from about 1.5 L to about 2.5 L of an
isotonic solution following the bowel movement; and d) thereafter allowing the mammal to evacuate the bowels and colon; e) the method optionally including the further step of administering a clear liquid to the mammal after administration of the
bisacodyl; whereby the colon is adequately cleansed to permit diagnostic testing or surgery.
2. The method of claim 1, wherein the amount of the isotonic solution is about 2 L.
3. The method of claim 1, wherein the amount of bisacodyl is from about 10 mg to about 20 mg.
4. The method of claim 1, whereby preparation time of the bowels and colon and adverse symptoms in the mammal are diminished.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.